Insider Transactions in Q1 2022 at Cyclo Therapeutics, Inc. (CYTH)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2022
|
Markus Sieger Director |
BUY
Open market or private purchase
|
Direct |
10,000
+10.91%
|
$20,000
$2.73 P/Share
|
|
Feb 07
2022
|
N Scott Fine Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,334
+6.65%
|
$31,002
$3.58 P/Share
|
|
Feb 04
2022
|
Francis Patrick Ostronic Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+3.9%
|
$15,000
$3.3 P/Share
|
|
Jan 28
2022
|
Markus Sieger Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,075
+5.38%
|
-
|
|
Jan 28
2022
|
Francis Patrick Ostronic Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,065
+4.11%
|
-
|
|
Jan 28
2022
|
Randall M. Toig Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,187
+4.51%
|
-
|
|
Jan 24
2022
|
Francis Patrick Ostronic Director |
BUY
Open market or private purchase
|
Direct |
2,000
+1.74%
|
$6,000
$3.75 P/Share
|
|
Jan 19
2022
|
Francis Patrick Ostronic Director |
BUY
Open market or private purchase
|
Direct |
1,132
+1.01%
|
$4,528
$4.0 P/Share
|
|
Jan 19
2022
|
N Scott Fine Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+3.58%
|
$15,000
$3.89 P/Share
|
|
Jan 14
2022
|
Francis Patrick Ostronic Director |
BUY
Open market or private purchase
|
Direct |
3,868
+1.74%
|
$15,472
$4.0 P/Share
|